Connection
Marc Bonaca to Liraglutide
This is a "connection" page, showing publications Marc Bonaca has written about Liraglutide.
|
|
Connection Strength |
|
 |
|
 |
|
0.201 |
|
|
|
-
Verma S, Al-Omran M, Leiter LA, Mazer CD, Rasmussen S, Saevereid HA, Sejersten Ripa M, Bonaca MP. Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease. Diabetes Obes Metab. 2022 07; 24(7):1288-1299.
Score: 0.201